ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 720194 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 720194; 2) Community: the network communities that were significantly associated with the response to NSC 720194; 3) Molecule: the relationships between components within communities and NSC 720194; 4) MDR: the compounds that were significantly associated with the NSC 720194.

NSC Compound Enrichment Correlation
NSC 752398 4-[5-(3,4-Dimethoxyphenyl)-2-(3,4,5-trimethoxybenzoyl)-3,4-dihydro-2H-pyrazol-3-yl]benzonitrile 0.0176693828663438 -0.082228409
NSC 720255 Null 0.0181211508101517 0.297234
NSC 9358 2-[[p-(dimethylamino)phenyl]azo]pyridine 0.0181211508101517 0.52840196
NSC 113951 6-Bromotoyocamycin 0.0181211508101519 0.31099634
NSC 314622 Indenoisoquinoline derivative 0.0181211508101519 0.15951336
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0181211508101519 0.55142298
NSC 53327 Null 0.0181211508101519 0.11676803
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0181211508101519 0.39886791
NSC 629974 7H-1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine, 3-(4-chlorophenyl)-6-(5-nitro-2-furanyl)- (9CI) 0.0181211508101519 0.33118648
NSC 638646 4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride 0.0181211508101519 0.26004054
Total:81  Current:28    [First] [Prev] [Next] [Last]